The use of a titanium-containing drug for the prevention of severe degrees of radiation mucositis in patients with metal structures in the oral cavity

Introduction. Oral mucositis is one of the earliest and most frequent complications of radiation therapy or chemotherapy in patients diagnosed with oropharyngeal cancer. Because of this pathology, therapeutic interventions are most often used, thereby poor treatment is considered an etiological fact...

Full description

Bibliographic Details
Main Authors: A. O. Sekretnaya, I. A. Zaderenko, S. Yu. Ivanov, S. B. Alieva, A. B. Dymnikov, R. R. Kaledin, H. Alsayed Hachem
Format: Article
Language:Russian
Published: ABV-press 2022-02-01
Series:Опухоли головы и шеи
Subjects:
Online Access:https://ogsh.abvpress.ru/jour/article/view/720
_version_ 1826558150276284416
author A. O. Sekretnaya
I. A. Zaderenko
S. Yu. Ivanov
S. B. Alieva
A. B. Dymnikov
R. R. Kaledin
H. Alsayed Hachem
author_facet A. O. Sekretnaya
I. A. Zaderenko
S. Yu. Ivanov
S. B. Alieva
A. B. Dymnikov
R. R. Kaledin
H. Alsayed Hachem
author_sort A. O. Sekretnaya
collection DOAJ
description Introduction. Oral mucositis is one of the earliest and most frequent complications of radiation therapy or chemotherapy in patients diagnosed with oropharyngeal cancer. Because of this pathology, therapeutic interventions are most often used, thereby poor treatment is considered an etiological factor of oral mucositis. Now, this issue is being actively studied in the world, but a unified algorithm for treatment and prevention of oral mucositis has not been formed.The study objective – is to evaluate the effect of titanium glycerosolvate aquacomplex in reducing the intensity of radiation induced reactions and reducing the frequency of interruptions.Materials and methods. 52 patients diagnosed with oropharyngeal cancer were included in this study, treated with radiotherapy or chemotherapy. For prophylaxis of severe stages of oral mucositis, 32 patients underwent standard symptomatic therapy (group 1, control group); 20 patients took titanium glycerosolvate aquacomplex in accordance with symptomatic therapy (group 2).Results. In the group 1 only 61.7 % of patients completed treatment. In the group 2 80 % of patients completely underwent antitumor therapy. At the same time, they developed oral mucositis of the I–II degree. Also, in the group of the studied drug, in 100 % of cases, therapy was performed without interruptions.Conclusion. Using titanium glycerosolvate aquacomplex for the prophylaxis of severe stages of oral mucositis during radiotherapy or chemotherapy of oropharyngeal cancer is effective and safe. It is also convenient from the medical and economic side, thanks to the ability to use it on an outpatient basis.
first_indexed 2024-04-10T01:58:34Z
format Article
id doaj.art-5ca6be0b293f4a2ab28533a632c705be
institution Directory Open Access Journal
issn 2222-1468
2411-4634
language Russian
last_indexed 2025-03-14T08:39:55Z
publishDate 2022-02-01
publisher ABV-press
record_format Article
series Опухоли головы и шеи
spelling doaj.art-5ca6be0b293f4a2ab28533a632c705be2025-03-02T12:53:52ZrusABV-pressОпухоли головы и шеи2222-14682411-46342022-02-01114818510.17650/2222-1468-2021-11-4-81-85472The use of a titanium-containing drug for the prevention of severe degrees of radiation mucositis in patients with metal structures in the oral cavityA. O. Sekretnaya0I. A. Zaderenko1S. Yu. Ivanov2S. B. Alieva3A. B. Dymnikov4R. R. Kaledin5H. Alsayed Hachem6Peoples’ Friendship University of RussiaPeoples’ Friendship University of Russia; N.N. Blokhin National Medical Research Center of Onсology, Ministry of Health of RussiaPeoples’ Friendship University of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Onсology, Ministry of Health of RussiaPeoples’ Friendship University of RussiaN.N. Blokhin National Medical Research Center of Onсology, Ministry of Health of RussiaPeoples’ Friendship University of RussiaIntroduction. Oral mucositis is one of the earliest and most frequent complications of radiation therapy or chemotherapy in patients diagnosed with oropharyngeal cancer. Because of this pathology, therapeutic interventions are most often used, thereby poor treatment is considered an etiological factor of oral mucositis. Now, this issue is being actively studied in the world, but a unified algorithm for treatment and prevention of oral mucositis has not been formed.The study objective – is to evaluate the effect of titanium glycerosolvate aquacomplex in reducing the intensity of radiation induced reactions and reducing the frequency of interruptions.Materials and methods. 52 patients diagnosed with oropharyngeal cancer were included in this study, treated with radiotherapy or chemotherapy. For prophylaxis of severe stages of oral mucositis, 32 patients underwent standard symptomatic therapy (group 1, control group); 20 patients took titanium glycerosolvate aquacomplex in accordance with symptomatic therapy (group 2).Results. In the group 1 only 61.7 % of patients completed treatment. In the group 2 80 % of patients completely underwent antitumor therapy. At the same time, they developed oral mucositis of the I–II degree. Also, in the group of the studied drug, in 100 % of cases, therapy was performed without interruptions.Conclusion. Using titanium glycerosolvate aquacomplex for the prophylaxis of severe stages of oral mucositis during radiotherapy or chemotherapy of oropharyngeal cancer is effective and safe. It is also convenient from the medical and economic side, thanks to the ability to use it on an outpatient basis.https://ogsh.abvpress.ru/jour/article/view/720oral mucositistitanium glycerosolvate aquacomplexmetal structures
spellingShingle A. O. Sekretnaya
I. A. Zaderenko
S. Yu. Ivanov
S. B. Alieva
A. B. Dymnikov
R. R. Kaledin
H. Alsayed Hachem
The use of a titanium-containing drug for the prevention of severe degrees of radiation mucositis in patients with metal structures in the oral cavity
Опухоли головы и шеи
oral mucositis
titanium glycerosolvate aquacomplex
metal structures
title The use of a titanium-containing drug for the prevention of severe degrees of radiation mucositis in patients with metal structures in the oral cavity
title_full The use of a titanium-containing drug for the prevention of severe degrees of radiation mucositis in patients with metal structures in the oral cavity
title_fullStr The use of a titanium-containing drug for the prevention of severe degrees of radiation mucositis in patients with metal structures in the oral cavity
title_full_unstemmed The use of a titanium-containing drug for the prevention of severe degrees of radiation mucositis in patients with metal structures in the oral cavity
title_short The use of a titanium-containing drug for the prevention of severe degrees of radiation mucositis in patients with metal structures in the oral cavity
title_sort use of a titanium containing drug for the prevention of severe degrees of radiation mucositis in patients with metal structures in the oral cavity
topic oral mucositis
titanium glycerosolvate aquacomplex
metal structures
url https://ogsh.abvpress.ru/jour/article/view/720
work_keys_str_mv AT aosekretnaya theuseofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT iazaderenko theuseofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT syuivanov theuseofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT sbalieva theuseofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT abdymnikov theuseofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT rrkaledin theuseofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT halsayedhachem theuseofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT aosekretnaya useofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT iazaderenko useofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT syuivanov useofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT sbalieva useofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT abdymnikov useofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT rrkaledin useofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity
AT halsayedhachem useofatitaniumcontainingdrugforthepreventionofseveredegreesofradiationmucositisinpatientswithmetalstructuresintheoralcavity